Retigabine is an anticonvulsant medication belonging to the class of potassium channel openers, primarily utilized as an adjunctive therapy for partial-onset seizures in adults who have not responded to… Read more
Retigabine is an anticonvulsant medication belonging to the class of potassium channel openers, primarily utilized as an adjunctive therapy for partial-onset seizures in adults who have not responded to other treatment options. In pharmaceutical analysis, identifying and quantifying the chemical profile of this drug is essential for ensuring patient safety and product efficacy. This category offers a comprehensive selection of reference standards, including the active pharmaceutical ingredient, its dihydrochloride salt, and various degradation products. Laboratories utilize these high-quality compounds, such as N-acetyl retigabine and specific nitroso derivatives, for rigorous impurity profiling and method validation. Additionally, the collection includes essential metabolites, such as glucuronide and glucoside conjugates, alongside stable isotope-labelled standards. These labelled forms are critical for precise quantitative analysis, enabling chemists to overcome matrix interference and achieve accurate results during quality control and stability testing throughout the drug development lifecycle.